The efficacy of betulinic acid in triple-negative breast cancer

PURPOSE: The treatment of triple-negative breast cancer remains a daunting challenge with the standard-of-care treatments eventually failing due to acquired drug resistance, toxic side effects and the presence of a deregulated immune response. New treatments for overcoming these drawbacks include th...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Daniel, Zhang, Mixia, Zhuang, Pengwei, Zhang, Yanjun, Wheat, Janelle, Currie, Geoffrey, Al-Eisawi, Zaynab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607226/
https://www.ncbi.nlm.nih.gov/pubmed/26770742
http://dx.doi.org/10.1177/2050312114551974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607226/
https://www.ncbi.nlm.nih.gov/pubmed/26770742
http://dx.doi.org/10.1177/2050312114551974

Ejemplares similares